Matches in Nanopublications for { ?s ?p "[Strategies incorporating FLT3-targeted agents into AML therapy are ongoing, but challenges in trial design, clinical heterogeneity and need for long-term follow-up make these investigations complicated in design and implementation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Strategies incorporating FLT3-targeted agents into AML therapy are ongoing, but challenges in trial design, clinical heterogeneity and need for long-term follow-up make these investigations complicated in design and implementation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1149256.RARPJuAyuoEi-vQD8Iyn_Pm4Dh1jr19cG9dpGWM_pzu0E130_assertion description "[Strategies incorporating FLT3-targeted agents into AML therapy are ongoing, but challenges in trial design, clinical heterogeneity and need for long-term follow-up make these investigations complicated in design and implementation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149256.RARPJuAyuoEi-vQD8Iyn_Pm4Dh1jr19cG9dpGWM_pzu0E130_provenance.